中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate

文献类型:期刊论文

作者Hait, Nitai C.3,4,5; Maiti, Aparna3,4,5; Xu, Pan1,6; Qi, Qianya2; Kawaguchi, Tsutomu3,4; Okano, Maiko3,4; Takabe, Kazuaki3,4; Yan, Li2; Luo, Cheng1,6
刊名FASEB JOURNAL
出版日期2020-02-04
页码18
关键词hypoxia-inducible factors sphingosine-1-phosphate sphingosine kinase 2 triple-negative breast cancer
ISSN号0892-6638
DOI10.1096/fj.201901734RR
通讯作者Hait, Nitai C.(nitai.hait@roswellpark.org)
英文摘要Sphingosine kinase 2 (SphK2) is known to phosphorylate the nuclear sphingolipid metabolite to generate sphingosine-1-phosphate (S1P). Nuclear S1P is involved in epigenetic regulation of gene expression; however, the underlying mechanisms are not well understood. In this work, we have identified the role of nuclear S1P and SphK2 in regulating hypoxia-responsive master transcription factors hypoxia-inducible factor (HIF)-1 alpha/2 alpha, and their functions in breast cancer, with a focus on triple-negative breast cancer (TNBC). We have shown SphK2 is associated with HIF-1 alpha in protein complexes, and is enriched at the promoters of HIF target genes, including vascular endothelial growth factor (VEGF), where it enhances local histone H3 acetylation and transcription. S1P specifically binds to the PAS domains of HIF-1 alpha. SphK2, and HIF-1 alpha expression levels are elevated in metastatic estrogen receptor-positive (ER+) and TNBC clinical tissue specimens compared to healthy breast tissue samples. To determine if S1P formation in the nucleus by SphK2 is a key regulator of HIF functions, we found using a preclinical TNBC xenograft mouse model, and an existing selective SphK2 inhibitor K-145, that nuclear S1P, histone acetylation, HIF-1 alpha expression, and TNBC tumor growth were all reduced in vivo. Our results suggest that S1P and SphK2 in the nucleus are linked to the regulation of HIF-1 alpha/2 alpha functions associated with breast cancer progression, and may provide potential therapeutic targets.
WOS关键词SPHINGOSINE KINASE 2 ; BREAST-CANCER ; HISTONE ACETYLATION ; EXPRESSION ; PROTEIN ; SPHK2 ; GROWTH ; ACID ; CHEMORESISTANCE ; OVEREXPRESSION
资助项目Roswell Park Cancer Institute (RPCI)[714084-01]
WOS研究方向Biochemistry & Molecular Biology ; Life Sciences & Biomedicine - Other Topics ; Cell Biology
语种英语
WOS记录号WOS:000511114000001
出版者FEDERATION AMER SOC EXP BIOL
源URL[http://119.78.100.183/handle/2S10ELR8/281695]  
专题新药研究国家重点实验室
通讯作者Hait, Nitai C.
作者单位1.Chinese Acad Sci, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai, Peoples R China
2.Roswell Park Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA
3.Roswell Park Comprehens Canc Ctr, Div Breast Surg, Buffalo, NY USA
4.Roswell Park Comprehens Canc Ctr, Dept Surg Oncol, Buffalo, NY USA
5.Roswell Park Comprehens Canc Ctr, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA
6.Univ Chinese Acad Sci, Sch Pharm, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Hait, Nitai C.,Maiti, Aparna,Xu, Pan,et al. Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate[J]. FASEB JOURNAL,2020:18.
APA Hait, Nitai C..,Maiti, Aparna.,Xu, Pan.,Qi, Qianya.,Kawaguchi, Tsutomu.,...&Luo, Cheng.(2020).Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate.FASEB JOURNAL,18.
MLA Hait, Nitai C.,et al."Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate".FASEB JOURNAL (2020):18.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。